- Home
- IMVT vs DV Comparison
IMVT vs DV Comparison
Compare IMVT & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- DV
- Stock Information
- Founded
- IMVT 2018
- DV 2008
- Country
- IMVT United States
- DV United States
- Employees
- IMVT N/A
- DV N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- DV Computer Software: Prepackaged Software
- Sector
- IMVT Health Care
- DV Technology
- Exchange
- IMVT Nasdaq
- DV Nasdaq
- Market Cap
- IMVT 2.8B
- DV 2.4B
- IPO Year
- IMVT N/A
- DV 2021
- Fundamental
- Price
- IMVT $15.80
- DV $14.36
- Analyst Decision
- IMVT Buy
- DV Buy
- Analyst Count
- IMVT 10
- DV 18
- Target Price
- IMVT $40.14
- DV $18.92
- AVG Volume (30 Days)
- IMVT 1.3M
- DV 3.2M
- Earning Date
- IMVT 08-05-2025
- DV 07-29-2025
- Dividend Yield
- IMVT N/A
- DV N/A
- EPS Growth
- IMVT N/A
- DV N/A
- EPS
- IMVT N/A
- DV 0.29
- Revenue
- IMVT N/A
- DV $681,128,000.00
- Revenue This Year
- IMVT N/A
- DV $13.75
- Revenue Next Year
- IMVT N/A
- DV $11.71
- P/E Ratio
- IMVT N/A
- DV $48.89
- Revenue Growth
- IMVT N/A
- DV 15.30
- 52 Week Low
- IMVT $12.72
- DV $11.52
- 52 Week High
- IMVT $34.47
- DV $23.11
- Technical
- Relative Strength Index (RSI)
- IMVT 53.39
- DV 51.55
- Support Level
- IMVT $15.11
- DV $14.10
- Resistance Level
- IMVT $17.08
- DV $16.59
- Average True Range (ATR)
- IMVT 0.76
- DV 0.59
- MACD
- IMVT -0.00
- DV -0.04
- Stochastic Oscillator
- IMVT 47.56
- DV 30.16
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.